| ß | 95% Confidence interval | p |
---|---|---|---|
Cumulative IV-PCA drug consumption during POD 1 (mL) | |||
 Adjusted for age, BMI, DM, hypertension, and intraoperative remifentanil consumption | |||
Linear trend among the IV-PCA vs. RSB vs. ITMB groups | −10.715 | − 16.403 - -5.026 | < 0.001 |